[]

Find Clinical Drug Pipeline Developments & Deals for Metronidazole Benzoate

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          Peptide Process CMC
                          Not Confirmed
                          Peptide Process CMC
                          Not Confirmed

                          Lead Product(s) : Metronidazole Benzoate

                          Therapeutic Area : Undisclosed

                          Study Phase : Phase I

                          Sponsor : Swiss Commission for Technology and Innovation | University of Basel | University Hospital, Basel | SocraTec R&D GmbH

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          September 22, 2016

                          Lead Product(s) : Metronidazole Benzoate

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Phase I

                          Sponsor : Swiss Commission for Technology and Innovation | University of Basel | University Hospital, Basel | SocraTec R&D GmbH

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          Verisfield UK Ltd. Greek Branch

                          Country arrow
                          Peptide Process CMC
                          Not Confirmed

                          Verisfield UK Ltd. Greek Branch

                          Country arrow
                          Peptide Process CMC
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          May 23, 2014

                          Lead Product(s) : Metronidazole Benzoate

                          Therapeutic Area : Infections and Infectious Diseases

                          Highest Development Status : Phase I

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank